Profile
Cynthia L.
Sundell worked as the Vice President of Pharmacology at AtheroGenics, Inc. from 1995 to 2009.
She also worked as the Vice President of Drug Development at ABIONYX Pharma SA.
Former positions of Cynthia L. Sundell
| Companies | Position | End |
|---|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Corporate Officer/Principal | 2009-07-13 |
| ABIONYX PHARMA | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| Private companies | 1 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
- Stock Market
- Insiders
- Cynthia L. Sundell
